Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice.
Bartell, Shoshana M
Baile, Clifton A
Podolsky, Robert H.
McIndoe, Richard A
MetadataShow full item record
AbstractBACKGROUND: Leptin, a cytokine-like protein, plays an important role in the regulation of body weight through inhibition of food intake and stimulation of energy expenditure. Leptin circulates in blood and acts on the brain, which sends downstream signals to regulate body weight. Leptin therapy has been successful in treating leptin deficient obese patients. However, high levels of leptin have been observed in more common forms of obesity indicating a state of leptin resistance which limits the application of leptin in the treatment of obesity. If the central effect of leptin could be by-passed and genes which respond to leptin treatment could be regulated directly, new therapeutic targets for the treatment of obesity may be possible. The purpose of this study was to identify genes and subsequent pathways correlated with leptin-mediated weight loss. METHODOLOGY/PRINCIPAL FINDINGS: WE UTILIZED MICROARRAY TECHNOLOGY TO COMPARE HEPATIC GENE EXPRESSION CHANGES AFTER TWO TYPES OF LEPTIN ADMINISTRATION: one involving a direct stimulatory effect when administered peripherally (subcutaneous: SQ) and another that is indirect, involving a hypothalamic relay that suppresses food intake when leptin is administered centrally (intracerebroventricular: ICV). We identified 214 genes that correlate with leptin mediated weight loss. Several biological processes such as mitochondrial metabolic pathways, lipid metabolic and catabolic processes, lipid biosynthetic processes, carboxylic acid metabolic processes, iron ion binding and glutathione S-transferases were downregulated after leptin administration. In contrast, genes involved in the immune system inflammatory response and lysosomal activity were found to be upregulated. Among the cellular compartments mitochondrion (32 genes), endoplasmic reticulum (22 genes) and vacuole (8 genes) were significantly over represented. CONCLUSIONS/SIGNIFICANCE: In this study we have identified key molecular pathways and downstream genes which respond to leptin treatment and are involved in leptin-mediated weight loss. Many of these genes have previously been shown to be associated with obesity; however, we have also identified a number of other novel target genes. Further investigation will be required to assess the possible use of these genes and their associated protein products as therapeutic targets for the treatment of obesity.
CitationPLoS One. 2010 Aug 16; 5(8):e12147
- Leptin regulates peripheral lipid metabolism primarily through central effects on food intake.
- Authors: Prieur X, Tung YC, Griffin JL, Farooqi IS, O'Rahilly S, Coll AP
- Issue date: 2008 Nov
- Leptin and insulin modulate nutrient partitioning and weight loss in ob/ob mice through regulation of long-chain fatty acid uptake by adipocytes.
- Authors: Fan X, Bradbury MW, Berk PD
- Issue date: 2003 Sep
- Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats.
- Authors: Shen L, Tso P, Wang DQ, Woods SC, Davidson WS, Sakai R, Liu M
- Issue date: 2009 Aug 4
- Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver.
- Authors: Liang CP, Tall AR
- Issue date: 2001 Dec 28
- Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
- Authors: Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N
- Issue date: 2013 Nov